Top Banner
Peripheral Nervous System Drugs
40

Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Jan 15, 2016

Download

Documents

Mabel Rice
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Peripheral Nervous System Drugs

Page 2: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Cholinergic Drugs

• Muscarinic agonists

• Muscarinic antagonists

• Ganglionic stimulants

• Ganglionic blockers

• Neuromuscular blockers

• Cholinesterase inhibitors: affects all cholinergic receptors

Page 3: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Parasympathetic Actions

Page 4: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Parasympathetic Receptors

Page 5: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Muscarinic Agonists(Parasympathomimetics)

• Limited uses:– Urinary retention– Increase GI peristalsis– Glaucoma, eye surgery

• Adverse effects– Bradycardia, hypotension– Excess saliva, cramps, diarrhea– Urinary (contra: bladder obstruction &surgery)– Asthma exacerbation

Page 6: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Muscarinic Poisoning

• Sources– Muscarinic agonists– Cholinesterase inhibitors– Mushrooms

• Symptoms– Profuse salivation, tearing, bronchospasm,

diarrhea, bradycardia, hypotension

• Treatment: atropine

Page 7: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Muscarinic Antagonists (Parasympatholytics)

• “Anticholinergics”• Agents

– Atropine: strongest, general use– Oxybutinin (Ditropan): overactive bladder– Tolerodine (Detrol): overactive bladder– Scopolamine: sedation, motion sickness– Ipratropium: lungs– Dicyclomine (Bentyl): IBS, diarrhea– Others: ophthalmic procedures, Parkinson’s

Page 8: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Atropine

• Mechanism: competitive blockade of muscarinic receptors. High doses will block nicotinic as well

• Pharmacologic effects:– Heart: increase heart rate– Exocrine Glands: decrease secretions– Relaxation of smooth muscle– Eye: mydriasis– CNS excitation

Page 9: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Atropine

• Dose dependent– Low dose

– High dose

– Glands: sweat, salivary, bronchial

– Heart– Eye

– Bladder– Intestine motility– Lung

– Stomach

Page 10: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Atropine

• Kinetics: PO, topically (eye), injection

• Therapeutic Uses– Preanesthesia– Eye surgery– Bradycardia– Intestinal hypertonicity, hypermotility– Muscarinic Agonist Poisoning

Page 11: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Adverse (Anticholinergic) Effects

• Xerostomia (Dry Mouth)• Blurred vision, photophobia• Elevation of IOP• Urinary retention• Constipation• Anhidrosis (no sweat)• Tachycardia• Asthma: secretions too thick and crusty• Dementia

Page 12: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Interactions

• Other drugs with anti-muscarinic effects– Antihistamines– Phenothiazine antipsychotics– Tricyclic antidepressants

Page 13: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Anticholinergic Toxicity

• Dry as a bone• Hot as a hare• Blind as a bat• Mad as a hatter

– **Must determine whether psychosis is real or anticholinergic

• Treatment:– Minimize absorption– Cholinesterase inhibitor

Page 14: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Cholinesterase Inhibitors

• Reversible– Neostigmine: myasthenia gravis– Physostigmine: anti-cholinergic antidote

• Irreversible– Used as insecticides– Developed in WW2 as “nerve gas”– One is used for glaucoma

Page 15: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Myasthenia Gravis

• Etiology: Antibodies against Nicotinic-M receptors

• Clinical manifestations: fatigue, muscular weakness, dyspnea

• Treatment– Cholinesterase inhibitors– Side effects: can cause accumulation of

acetylcholine and nicotinic-M and muscarinic receptors

Page 16: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Myasthenia Gravis

• Treatment– Side effects cont– Muscarinic effects– Neuromuscular blockade (toxicity)

Page 17: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Neuromuscular Blockers

• Neuromuscular Blockers– Paralytics– Repiratory depression, hypotension– Agents

• Nondepolarizing: tubocurarine, et al.• Depolarizing: succinylcholine

• Uses– Surgery– Mechanical Ventilation, ET intubation– Adjunct to ECT

Page 18: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Sympathetic Actions

Page 19: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Sympathetic Receptors

Page 20: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Adrenergic Agonists

• Activate alpha and beta receptors

• Catecholamines: – Broken down by MAO and COMT in liver and

intestine– Cannot be given orally, short half-life– Epinephrine, Norepinephrine, isoproterenol,

dopamine, dobutamine– Colorless solutions; color is sign of oxidation

Page 21: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Adrenergic Agonists

• Noncatecholamines– Can be given PO– Last longer in body– Ephedrine, phenylephrine, terbutaline

Page 22: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Receptor Specificity

• Dobutamine: Beta1

• Terbutaline: beta2

• Isoproterenol: beta1 & 2

• Epinephrine: alpha 1 & 2, beta1 & 2

• Relative selectivity– Selectivity declines as concentration rises

Page 23: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Alpha1 Stimulation• Therapeutic effects

– Vasoconstriction hemostasis– Nasal decongestion– Local anesthesia adjunct– Increase BP (intensive care, last resort)– Mydriasis

• Adverse effects– Hypertension– Necrosis– Bradycardia

Page 24: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Beta1 Activation

• Therapeutic Effects– Cardiac arrest– Heart Failure– Shock– A-V heart block– Kidney?

• Adverse effects– Altered HR, rhythm– Angina pectoris

Page 25: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Beta2 activation

• Therapeutic– Asthma– Preterm labor

• Adverse effects– Hyperglycemia– Tremor

Page 26: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Epinephrine

• Receptors: all alpha and beta• Therapeutic uses:

– Delay absorption of local anesthetics– Control superficial bleeding– Reduce nasal congestion– Raise BP– Mydriasis– AV block– Restart heart in cardiac arrest– Asthma– Anaphylactic shock

Page 27: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Epinephrine• Abosrption

– Inhalation: minimal– Injection

• Inactivation: MAO and COMT in liver• Adverse events

– Hypertensive crisis– Dysrythmias– Angina pectoris– Necrosis– Hyperglycemia

Page 28: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Epinephrine

• Interactoins– MAO inhibitors– Tricyclic antidepressants– Alpha-adrenergic blocking agents– Beta-adrenergic blocking agents

• Preparations– SC, IM, IV, Intracardiac, intraspinal,

inhalation,– Lidocaine with epi

Page 29: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Norepinephrine

• Receptor: alpha 1 & 2, beta1

• Therapeutic uses– Hypotensive state– Cardiac arrest

• Brand: Levophed

Page 30: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Isoprotenerenol

• Receptors: Beta1 and Beta2• Uses

– AV block– Shock– Asthma (no longer used in U.S.)– Bronchospasm (2° anesthesia)

• Adverse effects– Dysrhythmias, angina pectoris– Hyperglycemia

Page 31: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Dopamine

• Receptor: dopamine, alpha1, (beta1 high doses)

• Uses– Shock: heart and renal arteries– Heart failure– ARF: low dose (some studies call effectiveness

into question)

• Adverse Effects– Dysrhythmias, angina pectoris

Page 32: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Other Adrenergic Agonists

• Dobutamine (beta1): heart failure

• Terbutaline: (beta2):preterm labor, asthma

• Phenylephrine: (alpha1) nasal congestion

• Ephedrine (all alpha and beta):– Directly binds & ↑norepinephrine release– Nasal congestion– Narcolepsy– Can be used to make amphetamines

Page 33: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Adrenergic Antagonists

• Can be quite selective for receptors

Page 34: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Alpha1-antagogonists

• Therapeutic uses– Hypertension– BPH– Reverse toxicity of – Pheochomocytoma– Raynaud’s disease

• Adverse effects– Orthostatic

hypotension– Reflex tachycardia– Nasal Congestion– Inhibition of ejaculation– Na+ & H2O retention

Page 35: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Alpha-Adrenergic Blockers

• Prazosin - HTN

• Doxazosin – HTN, BPH

• Terazosin – HTN, BPH

• Tamsulosin – BPH

• Phentolamine – Pheochromocytoma, tissue necrosis

Page 36: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Beta-blockade

• Therapeutic Uses– Angina Pectoris– HTN– Dysrhythmias– MI– HF– Other

• Hyperthyroid• Migraine• Stage Fright• Pheochromocytoma• Glaucoma

• Adverse Effects (β1)– Bradycardia CO– Precipitate HF– AV heart block– Rebound cardiac

excitation

• Adverse Effects (β2)– Bronchoconstriction– Inhibition of

glycogenolysis

Page 37: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Beta antagonists

• Beta1, Beta2– Propanolol– Nadolol– Pindolol

• Selective– Metoprolol– Atenolol– Bisoprolol

• Beta1,beta2, alpha1– Labetalol– Carvedilol

• Used for HF– Metoprolol– Carvedilol

Page 38: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Indirect Adrenergic Antagonists

• Reserpine– Suppresses NE synthesis and promotes MAO-

mediated destruction– Crosses BBB– Effects

• Hypotension

– Adverse effects• Depression, sedation, apathy• Bradycardia, hypotension

• Guanethidine: similar but fewer CNS effect

Page 39: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Indirect Adrenergic Antagonists

• Clonidine– Causes activation of alpha-2 receptors in CNS– Uses

• Hypertension• Pain relief in cancer (epdidural use only)

– Adverse effects• Drowsiness, dry mouth, rebound HTN

– Preparations• Oral: at least twice a day• Transdermal: seven days

Page 40: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular.

Indirect Adrenergic Antagonists

• Methyldopa, Methyldopate– Similar to clonidine, but are taken up in brain

stem neurons and converted to active alpha2 agonist

– Use: HTN– Adverse effects

• 10 – 20% Positive Coombs test (5%) will go on to have hemolytic anemia

• Hepatotoxicity• Drowsiness, dry mouth, hypotension, etc.